APO Research

APO RESEARCH · REPORT

Armodafinil Tablets

Selected research

Industry Growth & Trends

Global Armodafinil Tablets Industry Growth and Trends Forecast to 2032

Market perspective

The global Armodafinil Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Armodafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Armodafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Armodafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Armodafinil Tablets include Sandoz, Mylan, Aurobindo Pharma, Natco Pharma, Lupin, Cephalon, Apotex and Actavis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Armodafinil Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Armodafinil Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Armodafinil Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Armodafinil Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Armodafinil Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Armodafinil Tablets Market by Company

Sandoz

Mylan

Aurobindo Pharma

Natco Pharma

Lupin

Cephalon

Apotex

Actavis

Armodafinil Tablets Segment by Type

150mg per Tablet

200mg per Tablet

250mg per Tablet

50mg per Tablet

Armodafinil Tablets Segment by Application

Obstructive Sleep Apnea

Shift Work Sleep Disorder

Narcolepsy

Other

Armodafinil Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Armodafinil Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Armodafinil Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Armodafinil Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Armodafinil Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Armodafinil Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 150mg per Tablet Table 2. Major Company of 200mg per Tablet Table 3. Major Company of 250mg per Tablet Table 4. Major Company of 50mg per Tablet Table 5. Global Armodafinil Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Armodafinil Tablets Sales by Type (2021-2026) & (K Units) Table 7. Global Armodafinil Tablets Sales Market Share in Volume by Type (2021-2026) Table 8. Global Armodafinil Tablets Sales by Type (2021-2026) & (US$ Million) Table 9. Global Armodafinil Tablets Sales Market Share in Value by Type (2021-2026) Table 10. Global Armodafinil Tablets Price by Type (2021-2026) & (US$/Unit) Table 11. Global Armodafinil Tablets Sales by Type (2027-2032) & (K Units) Table 12. Global Armodafinil Tablets Sales Market Share in Volume by Type (2027-2032) Table 13. Global Armodafinil Tablets Sales by Type (2027-2032) & (US$ Million) Table 14. Global Armodafinil Tablets Sales Market Share in Value by Type (2027-2032) Table 15. Global Armodafinil Tablets Price by Type (2027-2032) & (US$/Unit) Table 16. North America Armodafinil Tablets Sales by Type (2021-2026) & (K Units) Table 17. North America Armodafinil Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Armodafinil Tablets Sales by Type (2021-2026) & (K Units) Table 19. Europe Armodafinil Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Armodafinil Tablets Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Armodafinil Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Armodafinil Tablets Sales by Type (2021-2026) & (K Units) Table 23. Latin America Armodafinil Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Armodafinil Tablets Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Armodafinil Tablets Sales by Type (2021-2026) & (US$ Million) Table 26. Armodafinil Tablets Industry Trends Table 27. Armodafinil Tablets Industry Drivers Table 28. Armodafinil Tablets Industry Opportunities and Challenges Table 29. Armodafinil Tablets Industry Restraints Table 30. Global Armodafinil Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Armodafinil Tablets Revenue Market Share by Company (2021-2026) Table 32. Global Armodafinil Tablets Sales by Company (2021-2026) & (K Units) Table 33. Global Armodafinil Tablets Sales Share by Company (2021-2026) Table 34. Global Armodafinil Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Armodafinil Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Armodafinil Tablets Major Company Production Sites and Headquarters Table 37. Global Armodafinil Tablets Company, Product Type & Application Table 38. Global Armodafinil Tablets Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Armodafinil Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Armodafinil Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Armodafinil Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Armodafinil Tablets Sales Market Share in Volume by Region (2021-2026) Table 44. Global Armodafinil Tablets Sales by Region (2021-2026) & (US$ Million) Table 45. Global Armodafinil Tablets Sales Market Share in Value by Region (2021-2026) Table 46. Global Armodafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Armodafinil Tablets Sales by Region (2027-2032) & (K Units) Table 48. Global Armodafinil Tablets Sales Market Share in Volume by Region (2027-2032) Table 49. Global Armodafinil Tablets Sales by Region (2027-2032) & (US$ Million) Table 50. Global Armodafinil Tablets Sales Market Share in Value by Region (2027-2032) Table 51. Global Armodafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Armodafinil Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Armodafinil Tablets Sales by Application (2021-2026) & (K Units) Table 54. Global Armodafinil Tablets Sales Market Share in Volume by Application (2021-2026) Table 55. Global Armodafinil Tablets Sales by Application (2021-2026) & (US$ Million) Table 56. Global Armodafinil Tablets Sales Market Share in Value by Application (2021-2026) Table 57. Global Armodafinil Tablets Price by Application (2021-2026) & (US$/Unit) Table 58. Global Armodafinil Tablets Sales by Application (2027-2032) & (K Units) Table 59. Global Armodafinil Tablets Sales Market Share in Volume by Application (2027-2032) Table 60. Global Armodafinil Tablets Sales by Application (2027-2032) & (US$ Million) Table 61. Global Armodafinil Tablets Sales Market Share in Value by Application (2027-2032) Table 62. Global Armodafinil Tablets Price by Application (2027-2032) & (US$/Unit) Table 63. North America Armodafinil Tablets Sales by Application (2021-2026) & (K Units) Table 64. North America Armodafinil Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Armodafinil Tablets Sales by Application (2021-2026) & (K Units) Table 66. Europe Armodafinil Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Armodafinil Tablets Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Armodafinil Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Armodafinil Tablets Sales by Application (2021-2026) & (K Units) Table 70. Latin America Armodafinil Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Armodafinil Tablets Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Armodafinil Tablets Sales by Application (2021-2026) & (US$ Million) Table 73. Sandoz Company Information Table 74. Sandoz Business Overview Table 75. Sandoz Armodafinil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sandoz Armodafinil Tablets Product Portfolio Table 77. Sandoz Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Armodafinil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Mylan Armodafinil Tablets Product Portfolio Table 82. Mylan Recent Development Table 83. Aurobindo Pharma Company Information Table 84. Aurobindo Pharma Business Overview Table 85. Aurobindo Pharma Armodafinil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Aurobindo Pharma Armodafinil Tablets Product Portfolio Table 87. Aurobindo Pharma Recent Development Table 88. Natco Pharma Company Information Table 89. Natco Pharma Business Overview Table 90. Natco Pharma Armodafinil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Natco Pharma Armodafinil Tablets Product Portfolio Table 92. Natco Pharma Recent Development Table 93. Lupin Company Information Table 94. Lupin Business Overview Table 95. Lupin Armodafinil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lupin Armodafinil Tablets Product Portfolio Table 97. Lupin Recent Development Table 98. Cephalon Company Information Table 99. Cephalon Business Overview Table 100. Cephalon Armodafinil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Cephalon Armodafinil Tablets Product Portfolio Table 102. Cephalon Recent Development Table 103. Apotex Company Information Table 104. Apotex Business Overview Table 105. Apotex Armodafinil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Apotex Armodafinil Tablets Product Portfolio Table 107. Apotex Recent Development Table 108. Actavis Company Information Table 109. Actavis Business Overview Table 110. Actavis Armodafinil Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Actavis Armodafinil Tablets Product Portfolio Table 112. Actavis Recent Development Table 113. North America Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. North America Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 115. North America Armodafinil Tablets Sales Market Share by Country (2021-2026) Table 116. North America Armodafinil Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 117. North America Armodafinil Tablets Sales Market Share Forecast by Country (2027-2032) Table 118. North America Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Armodafinil Tablets Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Armodafinil Tablets Market Share by Country (2021-2026) Table 121. North America Armodafinil Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Armodafinil Tablets Market Share Forecast by Country (2027-2032) Table 123. Europe Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Europe Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 125. Europe Armodafinil Tablets Sales Market Share by Country (2021-2026) Table 126. Europe Armodafinil Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 127. Europe Armodafinil Tablets Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Armodafinil Tablets Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Armodafinil Tablets Market Share by Country (2021-2026) Table 131. Europe Armodafinil Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Armodafinil Tablets Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 135. Asia-Pacific Armodafinil Tablets Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Armodafinil Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 137. Asia-Pacific Armodafinil Tablets Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Armodafinil Tablets Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Armodafinil Tablets Market Share by Country (2021-2026) Table 141. Asia-Pacific Armodafinil Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Armodafinil Tablets Market Share Forecast by Country (2027-2032) Table 143. Latin America Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Latin America Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 145. Latin America Armodafinil Tablets Sales Market Share by Country (2021-2026) Table 146. Latin America Armodafinil Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 147. Latin America Armodafinil Tablets Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Armodafinil Tablets Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Armodafinil Tablets Market Share by Country (2021-2026) Table 151. Latin America Armodafinil Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Armodafinil Tablets Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 155. Middle East and Africa Armodafinil Tablets Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Armodafinil Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 157. Middle East and Africa Armodafinil Tablets Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Armodafinil Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Armodafinil Tablets Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Armodafinil Tablets Market Share by Country (2021-2026) Table 161. Middle East and Africa Armodafinil Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Armodafinil Tablets Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Armodafinil Tablets Distributors List Table 166. Armodafinil Tablets Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Armodafinil Tablets Image Figure 2. Global Armodafinil Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Armodafinil Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Armodafinil Tablets Sales (2021-2032) & (K Units) Figure 5. 150mg per Tablet Image Figure 6. Global 150mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 200mg per Tablet Image Figure 8. Global 200mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. 250mg per Tablet Image Figure 10. Global 250mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. 50mg per Tablet Image Figure 12. Global 50mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Armodafinil Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Armodafinil Tablets Market Share by Type 2025 VS 2032 Figure 15. North America Armodafinil Tablets Sales Market Share in Volume by Type in 2025 Figure 16. North America Armodafinil Tablets Sales Market Share in Value by Type in 2025 Figure 17. Europe Armodafinil Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Europe Armodafinil Tablets Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Armodafinil Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Armodafinil Tablets Sales Market Share in Value by Type in 2025 Figure 21. Latin America Armodafinil Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Armodafinil Tablets Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Armodafinil Tablets Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Armodafinil Tablets Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Armodafinil Tablets Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Obstructive Sleep Apnea Image Figure 28. Global Obstructive Sleep Apnea Sales YoY Growth (2021-2032) & (K Units) Figure 29. Shift Work Sleep Disorder Image Figure 30. Global Shift Work Sleep Disorder Sales YoY Growth (2021-2032) & (K Units) Figure 31. Narcolepsy Image Figure 32. Global Narcolepsy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Armodafinil Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Armodafinil Tablets Market Share by Application 2025 VS 2032 Figure 37. North America Armodafinil Tablets Sales Market Share in Volume by Application in 2025 Figure 38. North America Armodafinil Tablets Sales Market Share in Value by Application in 2025 Figure 39. Europe Armodafinil Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Europe Armodafinil Tablets Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Armodafinil Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Armodafinil Tablets Sales Market Share in Value by Application in 2025 Figure 43. Latin America Armodafinil Tablets Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Armodafinil Tablets Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Armodafinil Tablets Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Armodafinil Tablets Sales Market Share in Value by Application in 2025 Figure 47. North America Armodafinil Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Armodafinil Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Armodafinil Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Armodafinil Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Armodafinil Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Armodafinil Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Armodafinil Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Armodafinil Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Armodafinil Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Armodafinil Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Armodafinil Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Armodafinil Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Armodafinil Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Armodafinil Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Armodafinil Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Armodafinil Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Armodafinil Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Armodafinil Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Armodafinil Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Armodafinil Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Armodafinil Tablets Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Armodafinil Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg per Tablet
  • 200mg per Tablet
  • 250mg per Tablet
  • 50mg per Tablet
Applications
  • Obstructive Sleep Apnea
  • Shift Work Sleep Disorder
  • Narcolepsy
  • Other
Companies covered
  • Sandoz
  • Mylan
  • Aurobindo Pharma
  • Natco Pharma
  • Lupin
  • Cephalon
  • Apotex
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Armodafinil Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Armodafinil Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Armodafinil Tablets Market by Type
  6. 1.3.1 150mg per Tablet
  7. 1.3.2 200mg per Tablet
  8. 1.3.3 250mg per Tablet
  9. 1.3.4 50mg per Tablet
  10. 1.4 Global Armodafinil Tablets Market Size by Type
  11. 1.4.1 Global Armodafinil Tablets Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Armodafinil Tablets Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Armodafinil Tablets Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Armodafinil Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Armodafinil Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Armodafinil Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Armodafinil Tablets Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Armodafinil Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Armodafinil Tablets Industry Trends
  2. 2.2 Armodafinil Tablets Industry Drivers
  3. 2.3 Armodafinil Tablets Industry Opportunities and Challenges
  4. 2.4 Armodafinil Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Armodafinil Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Armodafinil Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Armodafinil Tablets Price (2021-2026)
  4. 3.4 Global Armodafinil Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Armodafinil Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Armodafinil Tablets Company, Product Type & Application
  7. 3.7 Global Armodafinil Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Armodafinil Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Armodafinil Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Armodafinil Tablets Tier 1, Tier 2, and Tier 3
4 Armodafinil Tablets Regional Status and Outlook
  1. 4.1 Global Armodafinil Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Armodafinil Tablets Historic Market Size by Region
  3. 4.2.1 Global Armodafinil Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Armodafinil Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Armodafinil Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Armodafinil Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Armodafinil Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Armodafinil Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Armodafinil Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Armodafinil Tablets by Application
  1. 5.1 Armodafinil Tablets Market by Application
  2. 5.1.1 Obstructive Sleep Apnea
  3. 5.1.2 Shift Work Sleep Disorder
  4. 5.1.3 Narcolepsy
  5. 5.1.4 Other
  6. 5.2 Global Armodafinil Tablets Market Size by Application
  7. 5.2.1 Global Armodafinil Tablets Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Armodafinil Tablets Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Armodafinil Tablets Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Armodafinil Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Armodafinil Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Armodafinil Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Armodafinil Tablets Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Armodafinil Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sandoz
  2. 6.1.1 Sandoz Company Information
  3. 6.1.2 Sandoz Business Overview
  4. 6.1.3 Sandoz Armodafinil Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sandoz Armodafinil Tablets Product Portfolio
  6. 6.1.5 Sandoz Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Armodafinil Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Armodafinil Tablets Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Aurobindo Pharma
  14. 6.3.1 Aurobindo Pharma Company Information
  15. 6.3.2 Aurobindo Pharma Business Overview
  16. 6.3.3 Aurobindo Pharma Armodafinil Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aurobindo Pharma Armodafinil Tablets Product Portfolio
  18. 6.3.5 Aurobindo Pharma Recent Developments
  19. 6.4 Natco Pharma
  20. 6.4.1 Natco Pharma Company Information
  21. 6.4.2 Natco Pharma Business Overview
  22. 6.4.3 Natco Pharma Armodafinil Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Natco Pharma Armodafinil Tablets Product Portfolio
  24. 6.4.5 Natco Pharma Recent Developments
  25. 6.5 Lupin
  26. 6.5.1 Lupin Company Information
  27. 6.5.2 Lupin Business Overview
  28. 6.5.3 Lupin Armodafinil Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lupin Armodafinil Tablets Product Portfolio
  30. 6.5.5 Lupin Recent Developments
  31. 6.6 Cephalon
  32. 6.6.1 Cephalon Company Information
  33. 6.6.2 Cephalon Business Overview
  34. 6.6.3 Cephalon Armodafinil Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cephalon Armodafinil Tablets Product Portfolio
  36. 6.6.5 Cephalon Recent Developments
  37. 6.7 Apotex
  38. 6.7.1 Apotex Company Information
  39. 6.7.2 Apotex Business Overview
  40. 6.7.3 Apotex Armodafinil Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Apotex Armodafinil Tablets Product Portfolio
  42. 6.7.5 Apotex Recent Developments
  43. 6.8 Actavis
  44. 6.8.1 Actavis Company Information
  45. 6.8.2 Actavis Business Overview
  46. 6.8.3 Actavis Armodafinil Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Actavis Armodafinil Tablets Product Portfolio
  48. 6.8.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Armodafinil Tablets Sales by Country
  2. 7.1.1 North America Armodafinil Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Armodafinil Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Armodafinil Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Armodafinil Tablets Market Size by Country
  6. 7.2.1 North America Armodafinil Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Armodafinil Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Armodafinil Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Armodafinil Tablets Sales by Country
  2. 8.1.1 Europe Armodafinil Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Armodafinil Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Armodafinil Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Armodafinil Tablets Market Size by Country
  6. 8.2.1 Europe Armodafinil Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Armodafinil Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Armodafinil Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Armodafinil Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Armodafinil Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Armodafinil Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Armodafinil Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Armodafinil Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Armodafinil Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Armodafinil Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Armodafinil Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Armodafinil Tablets Sales by Country
  2. 10.1.1 South America Armodafinil Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Armodafinil Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Armodafinil Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Armodafinil Tablets Market Size by Country
  6. 10.2.1 South America Armodafinil Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Armodafinil Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Armodafinil Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Armodafinil Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Armodafinil Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Armodafinil Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Armodafinil Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Armodafinil Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Armodafinil Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Armodafinil Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Armodafinil Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Armodafinil Tablets Value Chain Analysis
  2. 12.1.1 Armodafinil Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Armodafinil Tablets Production Mode & Process
  7. 12.2 Armodafinil Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Armodafinil Tablets Distributors
  10. 12.2.3 Armodafinil Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research